Business Context and Reporting Period
This Form 6-K filing is submitted by Genmab A/S, a foreign private issuer, for the month of March 2026. The report, dated March 9, 2026, serves to incorporate by reference a Company Announcement (Exhibit 99.1) into the registrant's existing registration statements on Form S-8.
Key Financial Metrics
The provided filing text contains only cover page and signature information. It does not provide clear values for revenue, profit, cash flow, margins, debt, liquidity, or other specific financial metrics. The financial data is presumably contained within the referenced Exhibit 99.1, which is not included in the input text.
Material Changes
No material changes versus prior periods are detailed in the provided text. The filing acts as a conduit for a separate announcement rather than a standalone financial report.
Guidance, Outlook, and Risks
The text does not contain management commentary, guidance, outlook, risks, contingencies, or details on unusual items. These elements are expected to be found in the full text of the Company Announcement referenced as Exhibit 99.1.
Investor Verification Checklist
- Verify the full content of Exhibit 99.1 (Company Announcement dated March 9, 2026) to obtain specific financial or operational details.
- Confirm the nature of the announcement (e.g., clinical trial results, partnership, or financial update) as the cover page does not specify the subject matter.
- Review the referenced Form S-8 registration statements to understand the context of the incorporation by reference.